WeylChem Acquires Catexel Businesses

WeylChem Acquires Catexel Businesses
WeylChem Acquires Catexel Businesses

International Chemical Investors Group (ICIG) and WeylChem Group together have acquired the Home Care, Cellulosics and Synthesis business of Catexel Group from Unilever Ventures.

With the buy WeylChem said it is broadening its portfolio of performance chemicals, thus gaining access to additional markets in industrial & institutional cleaning, textile bleaching, pulp bleaching and process technologies. The buy strengthens its leading position as supplier and manufacturer of oxidation catalysts and bleach activators, it added.

The transaction, which comprises the intellectual property of Catexel for a variety of applications, aso increases the innovation capabilities of the combined businesses through its dedicated R&D team, the German group said.

Andreas Maier, managing director of WeylChem Performance Products and head of the Consumer Care business unit, said the combination of its own and Catexel’s capabilities “creates a leading global expert in the field of oxidation catalysis.”

For ICIG, managing director Achim Riemann commented that the purchase fits well with its strategy to enhance its platforms by supporting add-on acquisitions.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.